Major Bayer shareholder Harris backs CEO’s focus on internal restructuring
Business & FinanceHealth
07 March 2024, 1:56 pm 1 minute
Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO.
Market Impact
The news caused Bayer’s shares to significantly narrow losses. The group’s stock closed down 0.9% following the comments after having fallen as much as 6.3% earlier in the session.
Article Tags
Topics of Interest: Business & FinanceHealth
Type: Reuters Best
Sectors: Business & FinancePharmaceuticals & Healthcare
Regions: Europe
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Important Regional Story